Pharma channel feed

Car­lyle’s Abing­worth will help fund Te­va’s Phase 3 asth­ma res­cue in­haler

Last year
Deals
R&D

Bris­tol My­er­s' Zeposia ex­pan­sion plans hit by Phase 3 set­back in Crohn's dis­ease

Last year
R&D

Genen­tech paves path to in­creased clin­i­cal tri­al di­ver­si­ty as a ‘busi­ness im­per­a­tive’

Last year
Marketing

J&J can try again to dis­pute ev­i­dence in mul­ti­dis­trict talc lit­i­ga­tion

Last year
Law

Nestlé Health Sci­ence plots next steps for C. diff drug Vow­st af­ter ro­bust up­take

Last year
Marketing

Up­dat­ed: US in­tel­li­gence of­fi­cials told Con­gress that WuXi trans­ferred IP to Chi­nese au­thor­i­ties — re­port

Last year
China

Gilead scores ex­pand­ed la­bel for he­pati­tis B drug Vem­lidy in chil­dren 6 years and old­er

Last year
FDA+

Bernie Sanders im­plores No­vo to cut list prices of Ozem­pic, We­govy

Last year
FDA+

Up­dat­ed: FDA ap­proves Ake­bi­a's ane­mia drug af­ter say­ing no in 2022

Last year
FDA+

Ovid asks USP­TO to re­view Mar­i­nus' patent around treat­ment of se­ri­ous seizure con­di­tion

Last year
Law

SK Life spot­lights epilep­sy aware­ness ef­forts like Uber rides, men­tor pro­gram and more on ‘Pur­ple Day’

Last year
Marketing

FDA’s CDER es­tab­lish­es new cen­ter of ex­cel­lence fo­cused on quan­ti­ta­tive med­i­cine

Last year
FDA+

On­copep­tides joins up with Vec­tor to com­mer­cial­ize blood can­cer drug Pepax­to in the Mid­dle East, North Africa

Last year

FDA ap­proves Mer­ck­'s rare PAH drug at cen­ter of $11.5B Ac­celeron deal

Last year
FDA+

SCO­TUS rais­es ques­tions over le­gal stand­ing in abor­tion pill case

Last year
FDA+
Law

Astel­las wins ap­proval in Japan for Claudin18.2 ther­a­py af­ter US re­jec­tion

Last year
FDA+

Ever­sana to work with pa­tient so­cial net­work to help phar­ma speed time to di­ag­no­sis and treat­ment

Last year
Marketing

Pfiz­er stops one of two Phase 3 tri­als for sick­le cell drug, still plans to seek ap­proval in 2026

Last year
R&D

In­sulin users face short­age with two of Eli Lil­ly's in­sulins through the be­gin­ning of April

Last year
Manufacturing

Mar­ket­ingRx roundup: Phar­ma ad­ver­tis­ers and March Mad­ness; No­vo lands near top of Fast Com­pa­ny's in­no­va­tion list

Last year
Marketing

Phath­om’s first cam­paign for acid block­er Vo­quez­na is the lat­est to use tele­health to reach po­ten­tial pa­tients di­rect­ly

Last year
Marketing

Alex­ion adds fourth in­di­ca­tion for C5 in­hibitor Ul­tomiris in rare au­toim­mune dis­or­der

Last year
R&D

NIH sends BioN­Tech 'no­tice of de­fault' over Covid vac­cine roy­al­ties

Last year
Coronavirus

As­traZeneca ad­vances Fasen­ra's mar­ket­ing with new cam­paign that's on Tik­Tok for first time

Last year
Marketing
First page Previous page 62636465666768 Next page Last page
A service from the Financial Times